Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.34788991 |
2 | negative regulation of cell killing (GO:0031342) | 6.34788991 |
3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.44714699 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.44714699 |
5 | modulation by symbiont of host immune response (GO:0052553) | 5.44714699 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.44714699 |
7 | modulation by symbiont of host defense response (GO:0052031) | 5.44714699 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.44714699 |
9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.23722748 |
10 | detection of other organism (GO:0098543) | 5.18263226 |
11 | detection of bacterium (GO:0016045) | 5.17544869 |
12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.90824062 |
13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.82299855 |
14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.82299855 |
15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.75069359 |
16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.68642175 |
17 | negative T cell selection (GO:0043383) | 4.60596946 |
18 | negative thymic T cell selection (GO:0045060) | 4.54395345 |
19 | leukocyte aggregation (GO:0070486) | 4.46029207 |
20 | macrophage activation involved in immune response (GO:0002281) | 4.37217623 |
21 | response to peptidoglycan (GO:0032494) | 4.28848820 |
22 | mast cell activation (GO:0045576) | 4.20584142 |
23 | cellular response to interleukin-15 (GO:0071350) | 4.20441168 |
24 | detection of external biotic stimulus (GO:0098581) | 4.17926088 |
25 | response to interleukin-15 (GO:0070672) | 4.10787408 |
26 | mast cell activation involved in immune response (GO:0002279) | 4.10626003 |
27 | mast cell degranulation (GO:0043303) | 4.10626003 |
28 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.08336488 |
29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.03734932 |
30 | B cell receptor signaling pathway (GO:0050853) | 4.00985687 |
31 | positive T cell selection (GO:0043368) | 3.94088787 |
32 | T cell selection (GO:0045058) | 3.93016364 |
33 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.91621833 |
34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.90021239 |
35 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.81932651 |
36 | negative regulation of interleukin-12 production (GO:0032695) | 3.80525313 |
37 | T cell migration (GO:0072678) | 3.79799632 |
38 | positive thymic T cell selection (GO:0045059) | 3.79152741 |
39 | regulation of gamma-delta T cell activation (GO:0046643) | 3.79097861 |
40 | response to host immune response (GO:0052572) | 3.76534744 |
41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.76534744 |
42 | thymic T cell selection (GO:0045061) | 3.73057836 |
43 | negative regulation of phagocytosis (GO:0050765) | 3.70204030 |
44 | detection of biotic stimulus (GO:0009595) | 3.62214559 |
45 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.62171152 |
46 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.58280377 |
47 | regulation of mast cell degranulation (GO:0043304) | 3.57430140 |
48 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.56429841 |
49 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.50048238 |
50 | detection of molecule of bacterial origin (GO:0032490) | 3.49656016 |
51 | response to muramyl dipeptide (GO:0032495) | 3.49402678 |
52 | response to host (GO:0075136) | 3.48522633 |
53 | response to host defenses (GO:0052200) | 3.48522633 |
54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.48522633 |
55 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.46883087 |
56 | synaptic vesicle maturation (GO:0016188) | 3.44162005 |
57 | locomotory exploration behavior (GO:0035641) | 3.41297420 |
58 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.34056641 |
59 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.31311079 |
60 | regulation of tolerance induction (GO:0002643) | 3.30658704 |
61 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.26773139 |
62 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.24470504 |
63 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.23580731 |
64 | signal complex assembly (GO:0007172) | 3.23387229 |
65 | microglial cell activation (GO:0001774) | 3.21369530 |
66 | B cell mediated immunity (GO:0019724) | 3.21369424 |
67 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.20871108 |
68 | neutrophil mediated immunity (GO:0002446) | 3.20212030 |
69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.19555389 |
70 | germinal center formation (GO:0002467) | 3.19418263 |
71 | regulation of leukocyte degranulation (GO:0043300) | 3.19396437 |
72 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.16292786 |
73 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.15913662 |
74 | regulation of B cell differentiation (GO:0045577) | 3.14883788 |
75 | leukocyte degranulation (GO:0043299) | 3.13555214 |
76 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.13536505 |
77 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.13536505 |
78 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.12743455 |
79 | activated T cell proliferation (GO:0050798) | 3.11945091 |
80 | T cell receptor signaling pathway (GO:0050852) | 3.10349895 |
81 | positive regulation of mast cell activation (GO:0033005) | 3.09979467 |
82 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.07326747 |
83 | myeloid cell activation involved in immune response (GO:0002275) | 3.07308059 |
84 | negative regulation of innate immune response (GO:0045824) | 3.06911182 |
85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.06522518 |
86 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04493959 |
87 | macrophage activation (GO:0042116) | 3.03646137 |
88 | mature B cell differentiation (GO:0002335) | 3.03486560 |
89 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.03210042 |
90 | regulation of mast cell activation (GO:0033003) | 3.00758940 |
91 | cellular extravasation (GO:0045123) | 3.00164117 |
92 | regulation of Rap GTPase activity (GO:0032317) | 2.99188992 |
93 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.98788809 |
94 | positive regulation of granulocyte differentiation (GO:0030854) | 2.97593022 |
95 | T cell costimulation (GO:0031295) | 2.96089306 |
96 | interferon-gamma production (GO:0032609) | 2.95732918 |
97 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.94096939 |
98 | positive regulation of Rap GTPase activity (GO:0032854) | 2.93744075 |
99 | negative regulation of interleukin-6 production (GO:0032715) | 2.92964758 |
100 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.92890433 |
101 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.92890433 |
102 | lymphocyte costimulation (GO:0031294) | 2.91687190 |
103 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.89893105 |
104 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.89615033 |
105 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.87235061 |
106 | respiratory burst (GO:0045730) | 2.86219199 |
107 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.84974997 |
108 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.83717918 |
109 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.83709520 |
110 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.83313094 |
111 | regulation of synapse structural plasticity (GO:0051823) | 2.82678698 |
112 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.82014237 |
113 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81660583 |
114 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.80217841 |
115 | positive regulation of lamellipodium assembly (GO:0010592) | 2.79306908 |
116 | regulation of defense response to virus by virus (GO:0050690) | 2.78703521 |
117 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.77580554 |
118 | response to type I interferon (GO:0034340) | 2.75362170 |
119 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.74753978 |
120 | type I interferon signaling pathway (GO:0060337) | 2.74576198 |
121 | cellular response to type I interferon (GO:0071357) | 2.74576198 |
122 | defense response to protozoan (GO:0042832) | 2.74112415 |
123 | immunoglobulin mediated immune response (GO:0016064) | 2.72812185 |
124 | negative regulation of T cell mediated immunity (GO:0002710) | 2.72294043 |
125 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.72210709 |
126 | positive regulation of interleukin-2 production (GO:0032743) | 2.71337272 |
127 | leukocyte cell-cell adhesion (GO:0007159) | 2.67353289 |
128 | neutrophil activation involved in immune response (GO:0002283) | 2.67245972 |
129 | regulation of regulatory T cell differentiation (GO:0045589) | 2.67148379 |
130 | tolerance induction (GO:0002507) | 2.66437600 |
131 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.64315792 |
132 | regulation of ARF protein signal transduction (GO:0032012) | 2.63216047 |
133 | positive regulation of B cell differentiation (GO:0045579) | 2.62905840 |
134 | synaptic vesicle exocytosis (GO:0016079) | 2.62901845 |
135 | response to protozoan (GO:0001562) | 2.60077704 |
136 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.60055666 |
137 | exploration behavior (GO:0035640) | 2.59766447 |
138 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.58437775 |
139 | neutrophil activation (GO:0042119) | 2.58386319 |
140 | mature B cell differentiation involved in immune response (GO:0002313) | 2.55753196 |
141 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.55574979 |
142 | adenosine receptor signaling pathway (GO:0001973) | 2.53579095 |
143 | granulocyte activation (GO:0036230) | 2.52734419 |
144 | regulation of T cell tolerance induction (GO:0002664) | 2.52060664 |
145 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.51978485 |
146 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.51978485 |
147 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.51978485 |
148 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.50821709 |
149 | lymphocyte migration (GO:0072676) | 2.49909779 |
150 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.47718091 |
151 | angiogenesis involved in wound healing (GO:0060055) | 2.47538488 |
152 | negative regulation of interleukin-17 production (GO:0032700) | 2.46820368 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.96348074 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.68351564 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.51174751 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.40129127 |
5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.47257705 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.39948459 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.33944400 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.18781422 |
9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.95521737 |
10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.89891640 |
11 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.84815256 |
12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.82436268 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.77751590 |
14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.68915386 |
15 | * MYC_22102868_ChIP-Seq_BL_Human | 2.64841164 |
16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.56851611 |
17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.53356003 |
18 | MYB_26560356_Chip-Seq_TH2_Human | 2.43551293 |
19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40602298 |
20 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40347341 |
21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.37650542 |
22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.37430399 |
23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36227446 |
24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33768100 |
25 | MAF_26560356_Chip-Seq_TH1_Human | 2.31519815 |
26 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.30938414 |
27 | SPI1_23127762_ChIP-Seq_K562_Human | 2.23152128 |
28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.17706429 |
29 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.10725465 |
30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.05543659 |
31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03483459 |
32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.03209249 |
33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.02126120 |
34 | MYB_26560356_Chip-Seq_TH1_Human | 2.00816777 |
35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.99700598 |
36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98229082 |
37 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87073002 |
38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.86960903 |
39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81103536 |
40 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.80248803 |
41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.78576524 |
42 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.71235746 |
43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70964631 |
44 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.70466285 |
45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.69473431 |
46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.69111968 |
47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63252744 |
48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61215532 |
49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61064987 |
50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.56290866 |
51 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.52251030 |
52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51950776 |
53 | MAF_26560356_Chip-Seq_TH2_Human | 1.46597885 |
54 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43523093 |
55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39080192 |
56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38953920 |
57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38542391 |
58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38514265 |
59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.36931918 |
60 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.35058126 |
61 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34221097 |
62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33949361 |
63 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29280086 |
64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26132022 |
65 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.25611938 |
66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.25573173 |
67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25145413 |
68 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.24133536 |
69 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.23392238 |
70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23213221 |
71 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21078448 |
72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.20903610 |
73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20623753 |
74 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.18333895 |
75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17281855 |
76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15513165 |
77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15402021 |
78 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.12363375 |
79 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11958062 |
80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11393264 |
81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11110815 |
82 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10295884 |
83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09687037 |
84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09006291 |
85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07125662 |
86 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06946642 |
87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06923829 |
88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06860823 |
89 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05022444 |
90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03940798 |
91 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03585553 |
92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03316380 |
93 | * P68_20966046_ChIP-Seq_HELA_Human | 1.02388409 |
94 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01305930 |
95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99798753 |
96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98440878 |
97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97312688 |
98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96991694 |
99 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.95278066 |
100 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92957200 |
101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92898659 |
102 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92182585 |
103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90634747 |
104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89338624 |
105 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.89189561 |
106 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.86639357 |
107 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.86532478 |
108 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86431463 |
109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86319174 |
110 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.85908906 |
111 | * SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.85666966 |
112 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.85556388 |
113 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.84738924 |
114 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84646887 |
115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84538321 |
116 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.84508991 |
117 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84145470 |
118 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81731248 |
119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81698580 |
120 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79339786 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0004859_abnormal_synaptic_plasticity | 4.22754956 |
2 | MP0001835_abnormal_antigen_presentation | 3.56629159 |
3 | MP0002822_catalepsy | 3.14289250 |
4 | MP0005671_abnormal_response_to | 3.02230192 |
5 | MP0003303_peritoneal_inflammation | 2.91980839 |
6 | MP0000685_abnormal_immune_system | 2.88946409 |
7 | MP0001800_abnormal_humoral_immune | 2.69596643 |
8 | MP0003880_abnormal_central_pattern | 2.68475002 |
9 | MP0005000_abnormal_immune_tolerance | 2.67636687 |
10 | MP0005387_immune_system_phenotype | 2.65670161 |
11 | MP0001790_abnormal_immune_system | 2.65670161 |
12 | MP0003763_abnormal_thymus_physiology | 2.65142955 |
13 | MP0004510_myositis | 2.63781821 |
14 | MP0003436_decreased_susceptibility_to | 2.58982975 |
15 | MP0009785_altered_susceptibility_to | 2.58639547 |
16 | MP0002723_abnormal_immune_serum | 2.42600466 |
17 | MP0002420_abnormal_adaptive_immunity | 2.41756017 |
18 | MP0001819_abnormal_immune_cell | 2.39771139 |
19 | MP0002452_abnormal_antigen_presenting | 2.39626912 |
20 | MP0002148_abnormal_hypersensitivity_rea | 2.31650690 |
21 | * MP0003635_abnormal_synaptic_transmissio | 2.29009788 |
22 | MP0005025_abnormal_response_to | 2.28077904 |
23 | MP0002419_abnormal_innate_immunity | 2.25709133 |
24 | MP0002398_abnormal_bone_marrow | 2.13309554 |
25 | MP0003191_abnormal_cellular_cholesterol | 2.06296639 |
26 | MP0009745_abnormal_behavioral_response | 2.05445775 |
27 | MP0006082_CNS_inflammation | 2.01069417 |
28 | MP0002132_abnormal_respiratory_system | 1.97794892 |
29 | MP0000716_abnormal_immune_system | 1.96092173 |
30 | MP0005464_abnormal_platelet_physiology | 1.95417410 |
31 | MP0003075_altered_response_to | 1.92910235 |
32 | MP0008260_abnormal_autophagy | 1.91360593 |
33 | * MP0002063_abnormal_learning/memory/cond | 1.88117244 |
34 | MP0002064_seizures | 1.80299612 |
35 | MP0005451_abnormal_body_composition | 1.69768413 |
36 | MP0002006_tumorigenesis | 1.69292245 |
37 | MP0002405_respiratory_system_inflammati | 1.69055543 |
38 | MP0005310_abnormal_salivary_gland | 1.66809576 |
39 | MP0002166_altered_tumor_susceptibility | 1.65583260 |
40 | MP0000689_abnormal_spleen_morphology | 1.65185006 |
41 | MP0002722_abnormal_immune_system | 1.61232262 |
42 | MP0003172_abnormal_lysosome_physiology | 1.60191617 |
43 | MP0001501_abnormal_sleep_pattern | 1.59043249 |
44 | MP0002429_abnormal_blood_cell | 1.53682852 |
45 | MP0004947_skin_inflammation | 1.52617451 |
46 | MP0000703_abnormal_thymus_morphology | 1.50734079 |
47 | MP0003300_gastrointestinal_ulcer | 1.48810219 |
48 | MP0001873_stomach_inflammation | 1.48383764 |
49 | MP0010155_abnormal_intestine_physiology | 1.47897362 |
50 | MP0004381_abnormal_hair_follicle | 1.47700109 |
51 | MP0001845_abnormal_inflammatory_respons | 1.46109617 |
52 | MP0001968_abnormal_touch/_nociception | 1.43003463 |
53 | * MP0002572_abnormal_emotion/affect_behav | 1.38379307 |
54 | MP0004808_abnormal_hematopoietic_stem | 1.36682452 |
55 | MP0001853_heart_inflammation | 1.36611321 |
56 | MP0003866_abnormal_defecation | 1.36232342 |
57 | MP0009333_abnormal_splenocyte_physiolog | 1.35597291 |
58 | MP0003828_pulmonary_edema | 1.35561045 |
59 | MP0002736_abnormal_nociception_after | 1.33137215 |
60 | MP0005058_abnormal_lysosome_morphology | 1.31426588 |
61 | MP0003724_increased_susceptibility_to | 1.31101088 |
62 | MP0000604_amyloidosis | 1.30561498 |
63 | MP0003329_amyloid_beta_deposits | 1.29136548 |
64 | MP0005166_decreased_susceptibility_to | 1.24047482 |
65 | MP0002277_abnormal_respiratory_mucosa | 1.22907067 |
66 | MP0008569_lethality_at_weaning | 1.19509706 |
67 | MP0002396_abnormal_hematopoietic_system | 1.19485028 |
68 | MP0008874_decreased_physiological_sensi | 1.18547836 |
69 | MP0005174_abnormal_tail_pigmentation | 1.17360661 |
70 | MP0003183_abnormal_peptide_metabolism | 1.16817561 |
71 | MP0002735_abnormal_chemical_nociception | 1.16236106 |
72 | MP0001533_abnormal_skeleton_physiology | 1.15273450 |
73 | MP0004270_analgesia | 1.12970689 |
74 | MP0001545_abnormal_hematopoietic_system | 1.12732315 |
75 | MP0005397_hematopoietic_system_phenotyp | 1.12732315 |
76 | MP0005075_abnormal_melanosome_morpholog | 1.11098107 |
77 | MP0000569_abnormal_digit_pigmentation | 1.06616377 |
78 | MP0002138_abnormal_hepatobiliary_system | 1.04560021 |
79 | MP0002909_abnormal_adrenal_gland | 1.04027692 |
80 | MP0004883_abnormal_blood_vessel | 1.02754359 |
81 | MP0000490_abnormal_crypts_of | 1.01381830 |
82 | MP0008469_abnormal_protein_level | 1.01279027 |
83 | MP0009278_abnormal_bone_marrow | 0.98285862 |
84 | MP0009046_muscle_twitch | 0.98153675 |
85 | * MP0002272_abnormal_nervous_system | 0.97832724 |
86 | MP0008961_abnormal_basal_metabolism | 0.96689710 |
87 | MP0000015_abnormal_ear_pigmentation | 0.95555811 |
88 | MP0003633_abnormal_nervous_system | 0.94010865 |
89 | MP0003879_abnormal_hair_cell | 0.93289969 |
90 | MP0000465_gastrointestinal_hemorrhage | 0.91798282 |
91 | MP0001851_eye_inflammation | 0.90219526 |
92 | MP0003787_abnormal_imprinting | 0.90136570 |
93 | MP0002933_joint_inflammation | 0.89983011 |
94 | MP0001486_abnormal_startle_reflex | 0.88295748 |
95 | MP0001970_abnormal_pain_threshold | 0.87740433 |
96 | MP0001986_abnormal_taste_sensitivity | 0.87603227 |
97 | MP0000858_altered_metastatic_potential | 0.86957966 |
98 | MP0003690_abnormal_glial_cell | 0.86224658 |
99 | * MP0004811_abnormal_neuron_physiology | 0.86161822 |
100 | MP0005167_abnormal_blood-brain_barrier | 0.85806866 |
101 | MP0010234_abnormal_vibrissa_follicle | 0.84310699 |
102 | MP0003806_abnormal_nucleotide_metabolis | 0.84179403 |
103 | MP0009763_increased_sensitivity_to | 0.83429372 |
104 | MP0002009_preneoplasia | 0.83002999 |
105 | MP0009764_decreased_sensitivity_to | 0.82157485 |
106 | MP0001663_abnormal_digestive_system | 0.77979039 |
107 | MP0001905_abnormal_dopamine_level | 0.76457344 |
108 | MP0005390_skeleton_phenotype | 0.75776109 |
109 | MP0005535_abnormal_body_temperature | 0.75116358 |
110 | MP0001440_abnormal_grooming_behavior | 0.74441059 |
111 | MP0003448_altered_tumor_morphology | 0.74076007 |
112 | MP0003045_fibrosis | 0.73775308 |
113 | MP0002733_abnormal_thermal_nociception | 0.70918163 |
114 | MP0000920_abnormal_myelination | 0.70642934 |
115 | MP0005164_abnormal_response_to | 0.70195825 |
116 | MP0004924_abnormal_behavior | 0.68290975 |
117 | MP0005386_behavior/neurological_phenoty | 0.68290975 |
118 | MP0000343_altered_response_to | 0.67727366 |
119 | MP0002019_abnormal_tumor_incidence | 0.65970871 |
120 | MP0002998_abnormal_bone_remodeling | 0.65926803 |
121 | MP0005423_abnormal_somatic_nervous | 0.65673712 |
122 | MP0008004_abnormal_stomach_pH | 0.63878968 |
123 | MP0003656_abnormal_erythrocyte_physiolo | 0.61365035 |
124 | MP0009765_abnormal_xenobiotic_induced | 0.61093388 |
125 | MP0003795_abnormal_bone_structure | 0.58345680 |
126 | MP0002928_abnormal_bile_duct | 0.55652284 |
127 | MP0000609_abnormal_liver_physiology | 0.54640205 |
128 | MP0000249_abnormal_blood_vessel | 0.53530938 |
129 | MP0005319_abnormal_enzyme/_coenzyme | 0.53380444 |
130 | MP0002693_abnormal_pancreas_physiology | 0.50787313 |
131 | MP0005083_abnormal_biliary_tract | 0.47737461 |
132 | MP0009840_abnormal_foam_cell | 0.45963092 |
133 | MP0004130_abnormal_muscle_cell | 0.44971168 |
134 | MP0003252_abnormal_bile_duct | 0.42851695 |
135 | MP0009642_abnormal_blood_homeostasis | 0.42160974 |
136 | MP0003878_abnormal_ear_physiology | 0.41261935 |
137 | MP0005377_hearing/vestibular/ear_phenot | 0.41261935 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 4.87376885 |
2 | Eczematoid dermatitis (HP:0000976) | 4.63206472 |
3 | Recurrent bacterial skin infections (HP:0005406) | 4.24476308 |
4 | Chronic otitis media (HP:0000389) | 4.20652254 |
5 | Gastrointestinal infarctions (HP:0005244) | 4.19394594 |
6 | Recurrent fungal infections (HP:0002841) | 4.04357512 |
7 | T lymphocytopenia (HP:0005403) | 3.93223422 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.91634714 |
9 | Myokymia (HP:0002411) | 3.87448704 |
10 | Focal motor seizures (HP:0011153) | 3.87219140 |
11 | Recurrent viral infections (HP:0004429) | 3.87213021 |
12 | Abnormality of T cell number (HP:0011839) | 3.82972830 |
13 | Mediastinal lymphadenopathy (HP:0100721) | 3.82618919 |
14 | Stomatitis (HP:0010280) | 3.72243202 |
15 | Recurrent bronchitis (HP:0002837) | 3.69314226 |
16 | IgM deficiency (HP:0002850) | 3.66418574 |
17 | Hypochromic microcytic anemia (HP:0004840) | 3.62023039 |
18 | Myositis (HP:0100614) | 3.54024501 |
19 | Panhypogammaglobulinemia (HP:0003139) | 3.48682283 |
20 | Increased IgE level (HP:0003212) | 3.41698634 |
21 | Urticaria (HP:0001025) | 3.41390951 |
22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.39423781 |
23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.32700222 |
24 | Hypochromic anemia (HP:0001931) | 3.31308499 |
25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.30780931 |
26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.30780931 |
27 | Meningitis (HP:0001287) | 3.27606427 |
28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.24837438 |
29 | Obstructive lung disease (HP:0006536) | 3.24837438 |
30 | Recurrent skin infections (HP:0001581) | 3.15572763 |
31 | Abnormality of T cells (HP:0002843) | 3.13094347 |
32 | Cellulitis (HP:0100658) | 3.12904313 |
33 | Nasal polyposis (HP:0100582) | 3.10500191 |
34 | Papilledema (HP:0001085) | 3.03570609 |
35 | Papilloma (HP:0012740) | 3.02361881 |
36 | Verrucae (HP:0200043) | 3.02361881 |
37 | Agammaglobulinemia (HP:0004432) | 3.02103178 |
38 | Pustule (HP:0200039) | 2.97510563 |
39 | Abnormality of macrophages (HP:0004311) | 2.92644876 |
40 | Autoimmune thrombocytopenia (HP:0001973) | 2.89850683 |
41 | Episodic fever (HP:0001954) | 2.88600792 |
42 | Vasculitis (HP:0002633) | 2.81256911 |
43 | Abnormality of the nasal mucosa (HP:0000433) | 2.77283877 |
44 | Visual hallucinations (HP:0002367) | 2.76174462 |
45 | Focal seizures (HP:0007359) | 2.76151000 |
46 | Lymphopenia (HP:0001888) | 2.75661950 |
47 | Gingival bleeding (HP:0000225) | 2.75329020 |
48 | Thyroiditis (HP:0100646) | 2.75176792 |
49 | Chronic sinusitis (HP:0011109) | 2.74045096 |
50 | Osteomyelitis (HP:0002754) | 2.72222470 |
51 | Inflammation of the large intestine (HP:0002037) | 2.71773253 |
52 | Gastrointestinal inflammation (HP:0004386) | 2.69115158 |
53 | Abnormality of B cell number (HP:0010975) | 2.67154866 |
54 | B lymphocytopenia (HP:0010976) | 2.67154866 |
55 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.65359257 |
56 | Anorexia (HP:0002039) | 2.65152065 |
57 | Pulmonary embolism (HP:0002204) | 2.63802565 |
58 | IgG deficiency (HP:0004315) | 2.62110441 |
59 | Recurrent sinusitis (HP:0011108) | 2.55839975 |
60 | Sepsis (HP:0100806) | 2.55127134 |
61 | Colitis (HP:0002583) | 2.51072045 |
62 | Annular pancreas (HP:0001734) | 2.47533724 |
63 | Prolonged bleeding time (HP:0003010) | 2.46501076 |
64 | Gingivitis (HP:0000230) | 2.46298820 |
65 | Severe combined immunodeficiency (HP:0004430) | 2.43597400 |
66 | Microcytic anemia (HP:0001935) | 2.43410575 |
67 | Combined immunodeficiency (HP:0005387) | 2.42420212 |
68 | Hypergammaglobulinemia (HP:0010702) | 2.35633807 |
69 | Spontaneous hematomas (HP:0007420) | 2.33920688 |
70 | Retrobulbar optic neuritis (HP:0100654) | 2.33887015 |
71 | Optic neuritis (HP:0100653) | 2.33887015 |
72 | Supranuclear gaze palsy (HP:0000605) | 2.32420297 |
73 | Abnormality of binocular vision (HP:0011514) | 2.31994244 |
74 | Diplopia (HP:0000651) | 2.31994244 |
75 | Eosinophilia (HP:0001880) | 2.31795892 |
76 | Purpura (HP:0000979) | 2.29532682 |
77 | Orchitis (HP:0100796) | 2.25469802 |
78 | Petechiae (HP:0000967) | 2.24777351 |
79 | Gastrointestinal stroma tumor (HP:0100723) | 2.24329910 |
80 | Skin ulcer (HP:0200042) | 2.23843909 |
81 | Abnormality of T cell physiology (HP:0011840) | 2.22712360 |
82 | Pulmonary infiltrates (HP:0002113) | 2.21905237 |
83 | Gangrene (HP:0100758) | 2.20513514 |
84 | Abnormality of the pleura (HP:0002103) | 2.19712630 |
85 | Chest pain (HP:0100749) | 2.19182027 |
86 | Thrombocytosis (HP:0001894) | 2.18530146 |
87 | Leukocytosis (HP:0001974) | 2.18045387 |
88 | Atonic seizures (HP:0010819) | 2.17552819 |
89 | Amyloidosis (HP:0011034) | 2.16245890 |
90 | Abnormality of eosinophils (HP:0001879) | 2.14968922 |
91 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14368971 |
92 | Viral hepatitis (HP:0006562) | 2.13852520 |
93 | Recurrent pneumonia (HP:0006532) | 2.13306771 |
94 | Keratoconjunctivitis sicca (HP:0001097) | 2.13300650 |
95 | Acute hepatic failure (HP:0006554) | 2.13079398 |
96 | Encephalitis (HP:0002383) | 2.12238911 |
97 | Hepatosplenomegaly (HP:0001433) | 2.12129668 |
98 | Skin rash (HP:0000988) | 2.10058737 |
99 | Peritonitis (HP:0002586) | 2.09557182 |
100 | Hemoptysis (HP:0002105) | 2.09413535 |
101 | Diminished motivation (HP:0000745) | 2.09092512 |
102 | Premature loss of primary teeth (HP:0006323) | 2.08393616 |
103 | Absence seizures (HP:0002121) | 2.07927867 |
104 | Mutism (HP:0002300) | 2.07666968 |
105 | Increased IgM level (HP:0003496) | 2.05729061 |
106 | Loss of speech (HP:0002371) | 2.05653827 |
107 | Recurrent lower respiratory tract infections (HP:0002783) | 2.04711896 |
108 | Apathy (HP:0000741) | 2.04500073 |
109 | Increased serum ferritin (HP:0003281) | 2.03663053 |
110 | Febrile seizures (HP:0002373) | 2.03104104 |
111 | Stereotypic behavior (HP:0000733) | 2.02969694 |
112 | Slow saccadic eye movements (HP:0000514) | 2.02518462 |
113 | Granulocytopenia (HP:0001913) | 2.02270638 |
114 | Abnormality of the peritoneum (HP:0002585) | 2.01866087 |
115 | Increased cerebral lipofuscin (HP:0011813) | 2.01289650 |
116 | Epistaxis (HP:0000421) | 1.99653986 |
117 | Arterial thrombosis (HP:0004420) | 1.99520491 |
118 | Glomerulopathy (HP:0100820) | 1.99065415 |
119 | Periodontitis (HP:0000704) | 1.98437428 |
120 | Bronchitis (HP:0012387) | 1.96199140 |
121 | Dysostosis multiplex (HP:0000943) | 1.95738583 |
122 | Dialeptic seizures (HP:0011146) | 1.95658855 |
123 | Acne (HP:0001061) | 1.94648696 |
124 | Keratoconjunctivitis (HP:0001096) | 1.94548016 |
125 | Vacuolated lymphocytes (HP:0001922) | 1.94523160 |
126 | Basal cell carcinoma (HP:0002671) | 1.94507687 |
127 | Ocular albinism (HP:0001107) | 1.94398160 |
128 | Emphysema (HP:0002097) | 1.93800138 |
129 | Autoimmune hemolytic anemia (HP:0001890) | 1.93598325 |
130 | Abnormal platelet volume (HP:0011876) | 1.93527307 |
131 | Abnormality of iron homeostasis (HP:0011031) | 1.93295643 |
132 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.92960082 |
133 | Hemiplegia (HP:0002301) | 1.92574428 |
134 | Hypertensive crisis (HP:0100735) | 1.92091176 |
135 | Joint swelling (HP:0001386) | 1.89377787 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.40028018 |
2 | MAP4K1 | 4.33532591 |
3 | MAP3K13 | 3.74828816 |
4 | EPHA4 | 3.73038755 |
5 | MAP3K9 | 2.88445908 |
6 | FES | 2.78492334 |
7 | MAP2K3 | 2.64543807 |
8 | TXK | 2.61182241 |
9 | GRK6 | 2.53171702 |
10 | NTRK3 | 2.23583409 |
11 | BLK | 2.20250476 |
12 | SIK2 | 2.18567222 |
13 | KSR2 | 2.06920767 |
14 | SYK | 2.02012490 |
15 | MAP3K12 | 1.91637564 |
16 | ZAP70 | 1.86827910 |
17 | ARAF | 1.84104906 |
18 | TYK2 | 1.70425950 |
19 | MAP3K11 | 1.67733730 |
20 | HCK | 1.65971505 |
21 | IKBKE | 1.63075862 |
22 | JAK3 | 1.62308644 |
23 | DAPK2 | 1.60817724 |
24 | DAPK1 | 1.56274745 |
25 | TAOK3 | 1.54747810 |
26 | JAK1 | 1.52258046 |
27 | MAP3K3 | 1.50922408 |
28 | ITK | 1.38866368 |
29 | KIT | 1.36995291 |
30 | CAMKK1 | 1.35906957 |
31 | IRAK4 | 1.35151995 |
32 | PRKCH | 1.34533967 |
33 | BTK | 1.33875786 |
34 | TESK2 | 1.32731769 |
35 | TBK1 | 1.32248719 |
36 | RAF1 | 1.31527621 |
37 | MAP3K14 | 1.27377446 |
38 | TNK2 | 1.23423411 |
39 | SMG1 | 1.20757907 |
40 | LCK | 1.20006939 |
41 | FGR | 1.18242676 |
42 | CSK | 1.15133994 |
43 | CLK1 | 1.09125432 |
44 | TEC | 1.07671613 |
45 | STK10 | 1.05824895 |
46 | PDK1 | 1.04671656 |
47 | CSF1R | 1.02054595 |
48 | MINK1 | 1.00725684 |
49 | BMPR2 | 1.00055358 |
50 | TAOK1 | 0.97657530 |
51 | LYN | 0.96021198 |
52 | PRKCQ | 0.94793888 |
53 | KSR1 | 0.94487650 |
54 | YES1 | 0.94479057 |
55 | PTK2B | 0.94239021 |
56 | SIK3 | 0.93752306 |
57 | ALK | 0.93199227 |
58 | PTK6 | 0.89243105 |
59 | TAOK2 | 0.88406097 |
60 | PKN2 | 0.84241354 |
61 | MAP3K7 | 0.82688538 |
62 | CDK5 | 0.80980390 |
63 | MAP3K1 | 0.78356989 |
64 | MARK3 | 0.76419266 |
65 | JAK2 | 0.76062584 |
66 | LRRK2 | 0.72952575 |
67 | CAMK1 | 0.71592553 |
68 | FYN | 0.70149617 |
69 | PRPF4B | 0.67943044 |
70 | FGFR3 | 0.66015491 |
71 | MATK | 0.64010729 |
72 | PAK6 | 0.63821630 |
73 | PDPK1 | 0.62604373 |
74 | SIK1 | 0.62238065 |
75 | MAPK7 | 0.61829933 |
76 | IRAK1 | 0.61640901 |
77 | IRAK2 | 0.61197972 |
78 | CAMKK2 | 0.59879083 |
79 | EEF2K | 0.59844354 |
80 | ERN1 | 0.59264565 |
81 | HIPK2 | 0.58374605 |
82 | TRIB3 | 0.57247644 |
83 | FGFR4 | 0.56677335 |
84 | PIM1 | 0.54806575 |
85 | NTRK2 | 0.54788362 |
86 | CDK19 | 0.53129590 |
87 | KDR | 0.52259190 |
88 | IKBKB | 0.51764221 |
89 | TYRO3 | 0.51692284 |
90 | DYRK1B | 0.51603563 |
91 | CDC42BPA | 0.51301041 |
92 | MAP3K4 | 0.51247588 |
93 | MAP3K6 | 0.50455401 |
94 | CDK4 | 0.48338941 |
95 | MAP2K7 | 0.48097402 |
96 | PRKD3 | 0.47831594 |
97 | PRKD2 | 0.47655084 |
98 | MOS | 0.47413566 |
99 | MARK2 | 0.46906219 |
100 | GRK5 | 0.46782063 |
101 | STK11 | 0.46706015 |
102 | SGK3 | 0.46301423 |
103 | MAP3K10 | 0.45337436 |
104 | NLK | 0.44292384 |
105 | RPS6KL1 | 0.44112014 |
106 | RPS6KC1 | 0.44112014 |
107 | CDK12 | 0.42921110 |
108 | MAP2K2 | 0.41635208 |
109 | SCYL2 | 0.40003695 |
110 | PLK2 | 0.39830192 |
111 | MAP3K5 | 0.38307957 |
112 | PIK3CG | 0.37856420 |
113 | MAPKAPK2 | 0.37780266 |
114 | RET | 0.37666815 |
115 | MAP3K8 | 0.37629256 |
116 | PASK | 0.36552557 |
117 | DAPK3 | 0.36443488 |
118 | MAPK11 | 0.35286501 |
119 | NTRK1 | 0.35130682 |
120 | MAPK12 | 0.34535082 |
121 | RPS6KA6 | 0.34465069 |
122 | PRKCG | 0.34423278 |
123 | MAP3K2 | 0.34265990 |
124 | PRKCD | 0.34104334 |
125 | STK38 | 0.32131090 |
126 | MAP2K6 | 0.31904935 |
127 | EPHB1 | 0.31193295 |
128 | CAMK4 | 0.30678262 |
129 | SGK1 | 0.29843887 |
130 | MAP2K4 | 0.27447838 |
131 | CAMK2B | 0.27359171 |
132 | EGFR | 0.25910383 |
133 | TNIK | 0.25630489 |
134 | TGFBR2 | 0.23470087 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.74494037 |
2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.64745179 |
3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.34879126 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.18053817 |
5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.06503286 |
6 | Olfactory transduction_Homo sapiens_hsa04740 | 1.99641915 |
7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.98156938 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.90062050 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.82050075 |
10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.81035891 |
11 | Viral myocarditis_Homo sapiens_hsa05416 | 1.79614407 |
12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.69876656 |
13 | Nicotine addiction_Homo sapiens_hsa05033 | 1.68858705 |
14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.63574381 |
15 | Malaria_Homo sapiens_hsa05144 | 1.61913888 |
16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.61871066 |
17 | Morphine addiction_Homo sapiens_hsa05032 | 1.59022971 |
18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.51310190 |
19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.50141850 |
20 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.49486509 |
21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.47172482 |
22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43119526 |
23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42171247 |
24 | Tuberculosis_Homo sapiens_hsa05152 | 1.41012084 |
25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.40442023 |
26 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.38818691 |
27 | Salivary secretion_Homo sapiens_hsa04970 | 1.38084658 |
28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35703626 |
29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.34652342 |
30 | Measles_Homo sapiens_hsa05162 | 1.31234810 |
31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.28030580 |
32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27210205 |
33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26640712 |
34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25064368 |
35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24675221 |
36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.22596100 |
37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22056284 |
38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21826031 |
39 | Phagosome_Homo sapiens_hsa04145 | 1.18034631 |
40 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.17624882 |
41 | Allograft rejection_Homo sapiens_hsa05330 | 1.16814289 |
42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.15109200 |
43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.14988593 |
44 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14771853 |
45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.13547195 |
46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.12046389 |
47 | Shigellosis_Homo sapiens_hsa05131 | 1.11966944 |
48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.10380413 |
49 | GABAergic synapse_Homo sapiens_hsa04727 | 1.09446696 |
50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.09434607 |
51 | Salmonella infection_Homo sapiens_hsa05132 | 1.08866279 |
52 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.07434837 |
53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07218292 |
54 | Pertussis_Homo sapiens_hsa05133 | 1.07145493 |
55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06034949 |
56 | Renin secretion_Homo sapiens_hsa04924 | 1.03882317 |
57 | Platelet activation_Homo sapiens_hsa04611 | 1.03289252 |
58 | Hepatitis C_Homo sapiens_hsa05160 | 1.02042631 |
59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99880097 |
60 | Glioma_Homo sapiens_hsa05214 | 0.99868266 |
61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99520277 |
62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97513143 |
63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.94227205 |
64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94202282 |
65 | Hepatitis B_Homo sapiens_hsa05161 | 0.92698265 |
66 | Apoptosis_Homo sapiens_hsa04210 | 0.92376688 |
67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92143421 |
68 | Influenza A_Homo sapiens_hsa05164 | 0.91910882 |
69 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91334272 |
70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.89893341 |
71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88937513 |
72 | Long-term depression_Homo sapiens_hsa04730 | 0.87380691 |
73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85815750 |
74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84361515 |
75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84251568 |
76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83936124 |
77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.83773478 |
78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83717353 |
79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83536872 |
80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83000198 |
81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79886562 |
82 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.79578334 |
83 | Asthma_Homo sapiens_hsa05310 | 0.77351476 |
84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75414036 |
85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75326914 |
86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74580375 |
87 | Insulin secretion_Homo sapiens_hsa04911 | 0.74320313 |
88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72462698 |
89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71877282 |
90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70200382 |
91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.70167846 |
92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.69800891 |
93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69078914 |
94 | Endocytosis_Homo sapiens_hsa04144 | 0.69030964 |
95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68816548 |
96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68475196 |
97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68424123 |
98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67895237 |
99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67580595 |
100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66439220 |
101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65826705 |
102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62283710 |
103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61825714 |
104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61100987 |
105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61070296 |
106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59745639 |
107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59703150 |
108 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59250251 |
109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58480404 |
110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57947928 |
111 | Legionellosis_Homo sapiens_hsa05134 | 0.57799963 |
112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56833413 |
113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56511824 |
114 | Lysosome_Homo sapiens_hsa04142 | 0.55320831 |
115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54762302 |
116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54744911 |
117 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54716086 |
118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53766978 |
119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52868207 |
120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52685964 |
121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49807344 |
122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48854385 |
123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45416819 |
124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45290635 |
125 | Insulin resistance_Homo sapiens_hsa04931 | 0.45013724 |
126 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44990442 |
127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42195923 |
128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38944939 |
129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35763487 |
130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35573902 |
131 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34186217 |
132 | Amoebiasis_Homo sapiens_hsa05146 | 0.32161355 |